Adma Biologics, Inc.
ADMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001368514
No open-market purchases or sales by Adma Biologics, Inc. insiders were filed in the last 90 days; 322 institutions reported holding it in 13F filings for Q2 2026, worth $1.70B in total; superinvestors Duquesne Family Office and Fundsmith hold it.
Q1 2024 vs. Q4 2023
How the institutions holding Adma Biologics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 184 | 2 | 214 | +32 |
| Shares | 169.2M | 28.8K | 175.1M | +6.00M (+3.5%) |
| Value | $764.6M | $130.0K | $1.16B | +$391.5M (+51.2%) |
2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (51)
Institutions that held Adma Biologics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (19)
Institutions that held Adma Biologics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Tang Capital Management LLC | 1,360,000 | $6.15M |
| Caligan Partners LP | 473,087 | $2.14M |
| ExodusPoint Capital Management, LP | 303,596 | $1.37M |
| Point72 Asset Management, L.P. | 244,513 | $1.11M |
| Mesirow Financial Investment Management, Inc. | 78,605 | $376.1K |
| State Board of Administration of Florida Retirement System | 60,110 | $271.7K |
| Bayesian Capital Management, LP | 57,915 | $261.8K |
| TownSquare Capital, LLC | 33,280 | $150.4K |
| Eagle Asset Management Inc | 25,957 | $117.3K |
| Bailard, Inc. | 24,400 | $110.3K |
| Oxford Asset Management LLP | 18,330 | $82.9K |
| Mercer Global Advisors Inc | 15,500 | $70.0K |
| Cambridge Investment Research Advisors, Inc. | 15,000 | $68.0K |
| Simplex Trading, LLC | 14,714 | $66.0K |
| Hudson Bay Capital Management LP | 13,636 | $61.6K |
| Cynosure Management, LLC | 10,856 | $49.1K |
| Verdence Capital Advisors LLC | 10,786 | $48.8K |
| Global Wealth Management Investment Advisory, Inc. | 500 | $2.26K |
| Gradient Investments LLC | 1 | $5 |
Not filed for Q1 2024 yet (2)
Institutions that held Adma Biologics, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Spouting Rock Asset Management, LLC | 18,399 | $83.2K |
| Sawtooth Solutions, LLC | 10,355 | $46.8K |